---
layout: post
title:  "Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors, a FCCSS Study"
date:   2022-09-22 13:13:45 +0200
---

# Article

<dl>
<dt>Title</dt>
<dd>Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors, a FCCSS Study.</dd>

<dt>Status</dt>
<dd>Submitted.</dd>

<dt>Presentations</dt>
<dd>This work will be shown as a poster on the 19th of October 2022, at <a href="https://www.radres.org/">radres 2022</a>.</dd>

<dt>doi</dt>
<dd>None yet.</dd>
</dl>

# Abstract

*not published yet*

# Authors

Thibaud Charrier<sup>1,2,3,4</sup>,
Nadia Haddy PhD<sup>1,2,3</sup>,
Boris Schwartz Msc<sup>1,2,3</sup>,
Neige Journy PhD<sup>1,2,3</sup>,
Brice Fresneau MD-PhD<sup>1,6</sup>,
Charlotte Demoor-Goldschmidt MD-PhD<sup>2,3,15,16,17</sup>,
Ibrahima Diallo PhD<sup>8,9</sup>,
Aurore Surun MD<sup>10</sup>,
Isabelle Aerts MD<sup>10</sup>,
François Doz MD<sup>10,11</sup>,
Vincent Souchard Msc<sup>1,2,3</sup>,
Giao Vu-Bezin Msc<sup>1,2,3</sup>,
Anne Laprie MD<sup>14</sup>,
Sarah Lemler PhD<sup>13</sup>,
Véronique Letort PhD<sup>13</sup>,
Carole Rubino MD-PhD<sup>1,2,3</sup>,
Stéfania Chounta<sup>1,2,3,13</sup>,
Florent de Vathaire PhD<sup>1,2,3</sup>,
Aurélien Latouche PhD<sup>4,5</sup>,
Rodrigue S. Allodji PhD<sup>1,2,3,12</sup>

[expand]

1.  Université Paris-Saclay, Univ. Paris-Sud, UVSQ, CESP, Cancer and Radiation Team, Villejuif, France
1.  INSERM, CESP, Cancer and Radiation Team, F-94805 Villejuif, France
1.  Gustave Roussy, Department of Clinical Research, Cancer and Radiation Team, F-94805 Villejuif, France
1.  Institut Curie, PSL Research University, INSERM, U900, F-92210, Saint Cloud
1.  Conservatoire National des Arts et Métiers, Paris, France
1.  Gustave Roussy, Université Paris-Saclay, Department of Pediatric oncology, Villejuif, F-94805, France
1.  Chu de Nantes, Pediatric Oncology, 38 Bd Jean Monnet, Nantes, 44093, France
1.  Department of Radiation Oncology, Gustave Roussy, Villejuif, Paris, France
1.  Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, Paris-Saclay
University, Villejuif, Île-de-France, France
1.  SIREDO Oncology Center (Care, Innovationand Research for Children, Adolescents and Young Adults
with Cancer), Institut Curie, Paris, France
1.  Université Paris Cité, Paris, France
1.  Polytechnic School of Abomey-Calavi (EPAC), University of Abomey-Calavi, 01 P.O. Box 2009,
Cotonou, Benin
1.  Université Paris-Saclay, CentraleSupélec, Mathématiques et Informatique pour la Complexité et les
Systèmes, 91190, Gif-sur-Yvette
1.  Department of Radiation Oncology, Centre Antoine-Lacassagne, Nice, France
1.  Department of Pediatric Oncology, Centre Hospitalier Universitaire,4 rue Larrey, 49000 Angers, France
1.  Department of radiotherapy, Centre François Baclesse, 3 av du Général Harris, 14000 Caen, France
1.  Department of supportive care, Centre François Baclesse, 3 av du Général Harris, 14000 Caen, France

[/expand]

Corresponding author's email: {% if true %} *TBD* {% else %} !(mailto:Rodrigue.ALLODJI@gustaveroussy.fr) {% endif %}

# Reproductibility

All codes used for those analyses can be found on ![github](https://github.com/T-Charrier/Effect-of-SMN-on-CD-risk"), along with a fake dataset to work with.
